The authors concluded that GLP-1 receptor imaging with 111In labelled exendin-4 is a more sensitive method for the detection of insulinoma than CT/MRI and have substantial impact on a clinical management of patients with endogenous hyperinsulinemic hypoglycemia. Here, GLP1R is linked to pancreatic insulinoma.